Woolsey Pharmaceuticals, Inc. — Form D
Woolsey Pharmaceuticals, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-15. $19.7M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-10-15
- Form: D
- Accession: 0001804846-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $19.7M
- Investors: 41
- Date of first sale: 2021-07-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-417089
Issuer
- Name: Woolsey Pharmaceuticals, Inc.
- CIK: 0001804846
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 233 BROADWAY, SUITE 1750, NEW YORK, NY, 10279
- Phone: 212-586-2226
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| DAVID M GELIEBTER | Director | NEW YORK, NY |
| SVEN M JACOBSON | Director | NEW YORK, NY |
| DAVID M GELIEBTER | Executive Officer | NEW YORK, NY |
| SVEN M JACOBSON | Executive Officer | NEW YORK, NY |
Other filings by this issuer (2)
More